Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | 0.00% | +2.77% | +7.00% |
May. 15 | Athira Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Athira Pharma, Inc. Appoints Javier San Martin, M.D., as Chief Medical Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 98.5M |
---|---|---|---|---|---|
Net income 2024 * | -108M | Net income 2025 * | -134M | EV / Sales 2024 * | - |
Net cash position 2024 * | 254M | Net cash position 2025 * | 172M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.07
x | P/E ratio 2025 * |
-1.13
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.25% |
Latest transcript on Athira Pharma, Inc.
1 day | +0.39% | ||
1 week | +2.77% | ||
Current month | -0.76% | ||
1 month | +31.98% | ||
3 months | -33.33% | ||
6 months | +46.07% | ||
Current year | +7.00% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 19-07-10 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 23-05-17 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 21-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 22-01-26 |
John Fluke
BRD | Director/Board Member | 81 | 12-12-31 |
Joseph Edelman
BRD | Director/Board Member | 67 | 20-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +10.33% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 2.582 | +0.47% | 24 239 |
24-06-05 | 2.57 | +5.33% | 166,957 |
24-06-04 | 2.44 | -4.31% | 167,716 |
24-06-03 | 2.55 | -2.67% | 223,241 |
24-05-31 | 2.62 | +3.56% | 58,853 |
Delayed Quote Nasdaq, June 06, 2024 at 10:13 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.00% | 98.5M | |
+57.32% | 59.34B | |
+43.06% | 40.24B | |
-4.78% | 39.88B | |
-5.56% | 28.55B | |
+16.58% | 27.26B | |
-20.68% | 19.23B | |
+32.20% | 12.61B | |
+3.24% | 12.49B | |
+26.14% | 12.28B |
- Stock Market
- Equities
- ATHA Stock